bioRxivImmunologyPreprint
A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutinin
J. J. Guthmiller, J. Han, H. A. Utset, L. Li, L. Y.-L. Lan, C. Henry, C. T. Stamper, O. Stovicek, L. Gentles, H. L. Dugan, N.-Y. Zheng, S. T. Richey, M. E. Tepora, D. J. Bitar, S. Changrob, S. Strohmeier, M. Huang, A. Garcia-Sastre, R. Nachbagauer, P. Palese, J. D. Bloom, F. Krammer, L. Coughlan, A. B. Ward, P. C. Wilson
Abstract
Broadly neutralizing antibodies against influenza virus hemagglutinin (HA) have the potential to provide universal protection against influenza virus infections. Here, we report a distinct class of broadly neutralizing antibodies targeting an epitope toward the bottom of the HA stalk domain where HA is "anchored" to the viral membrane. Antibodies targeting this membrane-proximal anchor epitope utilized a highly restricted repertoire, which encode for two conserved motifs responsible for HA binding. Anchor targeting B cells were common in the human memory B cell repertoire across subjects, indicating pre-existing immunity against this epitope. Antibodies against the anchor epitope at both the serological and monoclonal antibody levels were potently induced in humans by a chimeric HA vaccine, a potential universal influenza virus vaccine. Altogether, this study reveals an underappreciated class of broadly neutralizing antibodies against H1-expressing viruses that can be robustly recalled by a candidate universal influenza virus vaccine.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface
H. C. Simmons, J. Finney, … K. R. McCarthy·bioRxiv·Dec 13, 2023
- Membrane-anchored influenza neuraminidase vaccine drives human-like broadly protective B cell responses
Rui Liu, Chaohui Lin, … Zeli Zhang·bioRxiv·May 15, 2026
- Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor binding head domains
H. L. Turner, J. Pallesen, … A. B. Ward·bioRxiv·Oct 5, 2018
- Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection
Zhao-Shan Chen, Hsiang‐Chi Huang, … Davide Angeletti·Nature CommunicationsPeer-reviewed·Jan 9, 2025
- Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies
Daniel P. Maurer, Mya L. Vu, … Aaron G. Schmidt·Science AdvancesPeer-reviewed·Apr 23, 2025
- Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses
S. M. Moin, J. C. Boyington, … M. Kanekiyo·bioRxiv·Feb 11, 2022